
Siloxon 250 TZ Injection
Marketer
Silicon Pharma
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Siloxon 250 TZ Injection
Tazicef 250 Injection, a dual-action medication, combats various bacterial infections. Its mechanism inhibits microbial growth, halting infection progression. Administration must be solely under a healthcare provider's guidance. Consistent adherence to the prescribed dosage schedule is crucial; completing the full treatment course is vital, even with symptom improvement. Premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects warrant immediate medical consultation. Seek immediate medical attention for allergic reactions (skin rashes, pruritus, edema, respiratory distress). Inform your physician of all concurrent medications, especially if you are pregnant, breastfeeding, or have pre-existing health concerns. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, proper nutrition, and hydration contribute to faster recovery. Your doctor might order blood tests and imaging to assess the medicine's impact.
Primary Ingredients of Siloxon 250 TZ Injection
The provided text is "undefined," which lacks meaning and cannot be rephrased. A meaningful input is required to generate a unique rephrased version.
Uses of Siloxon 250 TZ Injection
Infections caused by bacteria
Major Benefits of Siloxon 250 TZ Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Siloxon 250 TZ Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Siloxon 250 TZ Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Siloxon 250 TZ Injection works:
Ceftriaxone and Tazobactum, the active components of Siloxon 250 TZ Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, thereby hindering bacterial growth. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Siloxon 250 TZ Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Siloxon 250 TZ is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Siloxon 250 TZ Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Siloxon 250 TZ Injection could lead to drowsiness, visual disturbances, and dizziness, potentially impairing alertness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Siloxon 250 TZ Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Exercise caution when administering Siloxon 250 TZ Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical advice before proceeding. Dosage alteration for Siloxon 250 TZ Injection is unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Siloxon 250 TZ Injection :
Should you inadvertently omit a Siloxon 250 TZ Injection, seek medical advice.
Facts to Know About Siloxon 250 TZ Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
